Rising cases of corona infection in India

- Photo: istock

The increasing cases of corona infection in the country continue to be a cause of concern. For the last six consecutive days, more than 12 thousand infected cases are being reported daily. While 12899 people were found infected on Sunday, on Monday this figure was close to 12781. In this way, now the active cases in the country have crossed 73 thousand. Currently, the daily positivity rate is 2.89% while the weekly positivity rate remains close to 2.50.

Health experts say that the way there is a jump in the number of infections, everyone needs to keep taking measures to prevent it.

According to experts from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), mainly Omicron and its sub-variants (BA.2 and BA.2.38) are believed to be the main reasons for the increasing cases of infection. BA.4 and BA.5 cases are also being reported in some parts of the country. All these variants are relatively highly contagious, so people who have completed their vaccination need to continue to take precautions.

Things getting worse due to the Omicron variant

Omicron sub-variants raise concerns

  • The INSACOG report shows that BA.2 and its sub-strain account for more than 85% of cases in the country. At the same time, less than 10% of samples of BA.4 and BA.5 have been found.
  • Mumbai is still the most affected state in India. Here the daily cases remain around 4000, with a slight decline on Sunday, 3883 cases of infection were found in people. At the same time, infection was confirmed in 1534 people in the national capital. To prevent corona, health experts are appealing to all people to take both doses of the vaccine.

Bharat Biotech Nasal Vaccine's Clinical Trial Completed

A clinical trial of the first nasal vaccine completed

  • There is news of relief regarding vaccination amidst increasing cases of infection. Bharat Biotech has completed the clinical trial of the world's first COVID-19 nasal vaccine. Giving information, Dr Krishna Ella, President and MD, Bharat Biotech said that the data analysis of the clinical trial of the nasal vaccine is going on. If all goes well, we will be allowed to launch and this will be the world's first clinically proven nasal vaccine for COVID-19.

Effectiveness of Nasal Vaccine

Also effective on variants like Omicron

  • According to information obtained from the website of Bharat Biotech, the Intranasal Vaccine helps in stimulating the massive IgG, mucosal IgA, and T cell response. Since the coronavirus enters the body through the nose, this vaccine can help inactivate the virus before it enters the body by creating an immune response in the nasal mucosa.
  • According to scientists, this nasal vaccine may also prove effective in inactivating highly contagious coronaviruses such as Omicron and its sub-variants.

Vaccination of children

Vaccination of children under the age of five in America

  • Amidst the growing crisis of Corona, the US Food and Drug Administration has allowed vaccination for children under the age of 5. Vaccines will be available for children above 6 months of age in the country from this week. CDC officials say that although there is only a slight risk of Kovid-19 in children. However, since March 2020, it has been the fifth leading cause of death among children aged 1-4 years and the fourth leading cause of death among children under 1 year of age. Vaccination may play a special role in protecting against this risk.

Disclaimer: Kalamtimes does not claim nor take any responsibility regarding the information and information provided in the article. Consult your doctor for more details about the related disease mentioned in the above article.